Vertex believes in the science of possibility. Our researchers use an integrated, cross-disciplinary approach to drug design that has led to the creation of a broad and diverse pipeline of medicines in development. We believe that no scientific problem is too complex for our researchers. What others call impossible, we call motivation. At Vertex, scientists aren’t afraid to think big or take risks – in fact, that is encouraged. The reward? Vertex has multiple potential new medicines in clinical development and a research portfolio of dozens of new approaches to serious diseases.
Our current research focuses on:
- Cystic Fibrosis
- Infectious diseases, including viral infections, such as influenza, and bacterial infections
- Autoimmune diseases, such as rheumatoid arthritis
- Inflammatory Bowel Disease
- Neurological disorders, including pain, Huntington’s disease and multiple sclerosis